Luna Diabetes

Watch Out For

• Pre-revenue stage with unknown funding, cash runway, and financial stability — career continuity depends entirely on capital raises or exit.
• Minimal hiring activity (6 roles) and absence of published financials signal a very early, potentially under-capitalized venture with limited internal mobility.
• Only 1 active trial and no disclosed phase data suggests product development remains in preclinical/early validation; regulatory catalyst timeline is unclear.